Commerzbank Aktiengesellschaft FI raised its position in shares of Humana Inc (NYSE:HUM) by 36.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,803 shares of the insurance provider’s stock after buying an additional 482 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Humana were worth $447,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. WFG Advisors LP grew its stake in shares of Humana by 4.5% during the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after purchasing an additional 20 shares during the period. Fieldpoint Private Securities LLC purchased a new position in shares of Humana during the 3rd quarter valued at approximately $115,000. ClariVest Asset Management LLC purchased a new position in Humana in the 3rd quarter valued at $144,000. Daiwa SB Investments Ltd. lifted its holdings in Humana by 44.9% in the 4th quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock valued at $176,000 after purchasing an additional 220 shares in the last quarter. Finally, Pettee Investors Inc. purchased a new position in Humana in the 3rd quarter valued at $207,000. 94.13% of the stock is owned by institutional investors and hedge funds.
In other news, SVP Jody L. Bilney sold 7,054 shares of the business’s stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $247.89, for a total value of $1,748,616.06. Following the transaction, the senior vice president now owns 11,704 shares of the company’s stock, valued at $2,901,304.56. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Timothy S. Huval sold 1,382 shares of the business’s stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total value of $340,027.28. Following the completion of the transaction, the vice president now directly owns 11,557 shares in the company, valued at approximately $2,843,484.28. The disclosure for this sale can be found here. In the last three months, insiders sold 10,115 shares of company stock worth $2,501,627. Corporate insiders own 0.80% of the company’s stock.
HUM has been the topic of a number of research reports. Credit Suisse Group decreased their price objective on Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a report on Friday, November 10th. BMO Capital Markets lifted their price target on Humana from $290.00 to $300.00 and gave the stock an “outperform” rating in a report on Friday, November 10th. Royal Bank of Canada reiterated a “sector perform” rating and set a $242.00 price target (down previously from $245.00) on shares of Humana in a report on Thursday, November 9th. Cantor Fitzgerald reiterated a “hold” rating and set a $230.00 price target on shares of Humana in a report on Tuesday, December 5th. Finally, Jefferies Group upgraded Humana from a “hold” rating to a “buy” rating and set a $221.00 price target on the stock in a report on Friday, January 12th. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Humana presently has a consensus rating of “Buy” and an average target price of $270.47.
Humana Inc (HUM) traded down $0.17 during mid-day trading on Wednesday, reaching $267.90. The company had a trading volume of 512,355 shares, compared to its average volume of 1,200,677. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.61 and a current ratio of 1.85. Humana Inc has a 12-month low of $203.36 and a 12-month high of $293.35. The stock has a market capitalization of $36,767.10, a PE ratio of 16.06, a price-to-earnings-growth ratio of 1.45 and a beta of 0.93.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.00 by $0.06. Humana had a return on equity of 16.13% and a net margin of 4.55%. The company had revenue of $13.19 billion during the quarter, compared to analysts’ expectations of $13.14 billion. During the same quarter in the previous year, the business earned $2.34 earnings per share. The firm’s revenue for the quarter was up 2.4% on a year-over-year basis. research analysts predict that Humana Inc will post 13.84 EPS for the current fiscal year.
Humana declared that its Board of Directors has authorized a share buyback program on Thursday, December 14th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the insurance provider to buy shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company’s board of directors believes its stock is undervalued.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.75%. This is a positive change from Humana’s previous quarterly dividend of $0.40. Humana’s payout ratio is presently 9.59%.
WARNING: “Commerzbank Aktiengesellschaft FI Buys 482 Shares of Humana Inc (NYSE:HUM)” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/02/14/humana-inc-hum-shares-bought-by-commerzbank-aktiengesellschaft-fi.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.